Efficacy of posaconazole against rhizopus oryzae infection in silkworm

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Rhizopus oryzae causes fatal invasive mucormycosis, especially in immunocompromised patients. Posaconazole is used to treat mucormycosis caused by R. oryzae, which is resistant to fluconazole and voriconazole. We evaluated the efficacy of posaconazole against R. oryzae in vivo using a silkworm infection model at 37°C, the human body temperature. The level of pathogenicity differed among the R. oryzae isolates, and posaconazole prolonged the survival of infected silkworms. Therefore, the silkworm infection model is suitable for investigating the virulence factors of R. oryzae and developing antifungal agents for mucormycosis.

Author supplied keywords

Cite

CITATION STYLE

APA

Kurakado, S., Matsumoto, Y., & Sugita, T. (2021). Efficacy of posaconazole against rhizopus oryzae infection in silkworm. Medical Mycology Journal, 62(3), 53–57. https://doi.org/10.3314/mmj.21-00004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free